Examination of the preexisting scaffold composition (light intensity/mm3) (Figure 4B) representing ongoing ECM remodeling, showed increased amounts of proteoglycans (p = 0.0231) such as perlecan and lumican in IPF scaffolds at day 1 (Figure S3). The gene discussed is HSPG2; the disease is idiopathic pulmonary fibrosis.